Company Filing History:
Years Active: 2022
Title: Jingwen Wang: Innovator in Glycosaminoglycan Derivatives
Introduction
Jingwen Wang is a notable inventor based in Guangdong, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of glycosaminoglycan derivatives. Her work focuses on innovative methods that have the potential to impact cancer treatment.
Latest Patents
Jingwen Wang holds a patent for a glycosaminoglycan derivative and its preparation method. The patent, titled "Glycosaminoglycan derivative and preparation method therefor and use thereof," discloses a carboxylated glycosaminoglycan derivative. This invention is aimed at inhibiting tumor growth and/or metastasis, showcasing her commitment to advancing medical science.
Career Highlights
Wang is currently employed at Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Her role at this prominent pharmaceutical company allows her to apply her innovative ideas in a practical setting, contributing to the development of new therapeutic solutions.
Collaborations
Jingwen Wang collaborates with esteemed colleagues, including Lige Ren and Xuewen Jin. These partnerships enhance her research efforts and foster a collaborative environment for innovation.
Conclusion
Jingwen Wang is a pioneering inventor whose work in glycosaminoglycan derivatives holds promise for future cancer therapies. Her contributions to the pharmaceutical industry exemplify the impact of innovation in healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.